CREEGH PHARMACEUTICALS
Creegh Pharmaceuticals specializes in the pharmaceutical preparation industry. It was founded in 2018 and headquartered in Pittsburgh, Pennsylvania.
CREEGH PHARMACEUTICALS
Industry:
Health Care Medical Pharmaceutical
Founded:
2018-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
150 K USD
Similar Organizations
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Juniper Therapeutics
Juniper Therapeutics specializes in treating osteoarthritis.
KOS Pharmaceuticals
KOS Pharmaceuticals specializes in so-called lipid-management products.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Pharmaceutical Outsourcing
Pharmaceutical Outsourcing specializes in pharmaceutical and biopharmaceutical contract services.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Vertical Pharmaceuticals
Vertical Pharmaceuticals supplies niche over the counter and prescription pharmaceutical preparations.
Current Employees Featured
Founder
Investors List
Innovation Works
Innovation Works investment in Seed Round - Creegh Pharmaceuticals
Innovation Works
Innovation Works investment in Seed Round - Creegh Pharmaceuticals
More informations about "Creegh Pharmaceuticals"
Creegh Pharmaceuticals Company Profile 2024: Valuation, Funding ...
Creegh Pharmaceuticals General Information Description. Developer of pharmaceutical drugs intended to treat cancer. The company specializes in the development of novel drugs, …See details»
Creegh Pharmaceuticals - Funding, Financials, Valuation & Investors
Creegh Pharmaceuticals specializes in the pharmaceutical preparation industry. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
Creegh Pharmaceuticals, Inc. - Drug pipelines, Patents ... - Patsnap
100 Translational Medicine associated with Creegh Pharmaceuticals, Inc. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full …See details»
CREEGH PHARMACEUTICALS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CREEGH PHARMACEUTICALS, INC. of Pittsburgh, PA. Get the latest business insights from Dun & …See details»
Creegh Pharmaceuticals - Contacts, Employees, Board Members, …
Creegh Pharmaceuticals has 2 current employee profiles, including Founder, CEO, & President Bruce Freeman. Bruce Freeman Founder, CEO, & President Margaret Tarpey CFOSee details»
Creegh Pharmaceuticals - Products, Competitors, Financials, …
Creegh Pharmaceuticals was founded in 2018. Where is Creegh Pharmaceuticals's headquarters? Creegh Pharmaceuticals's headquarters is located at 5801 Wilkins Avenue, …See details»
CREEGH PHARMACEUTICALS INC. :: Pennsylvania (US)
Mar 6, 2018 Free and open company data on Pennsylvania (US) company CREEGH PHARMACEUTICALS INC. (company number 6681317), 215 Park Rd, CARNEGIE, PA, 15106See details»
CREEGH PHARMACEUTICALS, INC. - CAGE.report
CREEGH PHARMACEUTICALS, INC. CAGE CODE 8CE22. Inc. Creegh Pharmaceuticals has a registered in the System for Award Management for doing business with and bidding for …See details»
Creegh Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
See Creegh Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Creegh Pharmaceuticals's post-money valuation and revenue.See details»
RePORT 〉 RePORTER
Awardee Organization CREEGH PHARMACEUTICALS, INC. Description. Abstract Text. 15-20% of all breast cancers are triple negative, being devoid of the three receptors that classify and …See details»
Creegh Pharmaceuticals - Crunchbase
Creegh Pharmaceuticals specializes in the pharmaceutical preparation industry.See details»
CREEGH PHARMACEUTICALS INC | SBIR.gov
15-20% of all breast cancers are triple negative, being devoid of the three receptors that classify and define treatment strategies for most mammary cancers: estrogen receptor (ER), …See details»
Bruce Freeman - Irwin Fridovich Distinguished Professor and …
UPMC/Irwin Fridovich Distinguished Professor and Chair; Department of Pharmacology & Chemical Biology; Scientific Co-founder, CEO, President; Creegh Pharmaceuticals · …See details»
Fostering Scientific Innovation to Impact AKI: A Roadmap from …
Aug 8, 2022 A. Agarwal reports consultancy for Akebia Therapeutics and Dynamed; serving on the medical advisory board of Creegh Pharmaceuticals; ownership interest in Creegh …See details»
Joshua Tarnoff Profile: Contact Information & Network - PitchBook
Mr. Joshua Tarnoff serves as Board Member at Creegh Pharmaceuticals. Contact Information. Primary Position. Board Member, Creegh Pharmaceuticals. Gender. Male. Phone +1 (412) …See details»
Breaking Ground for Canada’s Largest Critical Medicines ... - API
Jun 20, 2024 Expanding our level of Contract Development and Manufacturing Organization (CDMO) support, the CMPC will develop small-molecule active pharmaceutical ingredients …See details»
Creegh Pharmaceuticals - Updates, News, Events, Signals & Triggers
Nov 12, 2021 Creegh Pharmaceuticals specializes in the pharmaceutical preparation industry.See details»
Bruce Freeman - Founder, CEO, & President @ Creegh …
Primary Organization . Creegh Pharmaceuticals . Location Pittsburgh, Pennsylvania, United States; ... CEO, & President at Creegh Pharmaceuticals. University of Pittsburgh Irwin …See details»
Ottawa getting $40 million refund from former parent company of …
Dec 8, 2023 Ottawa will be getting a $40 million refund after it gave Quebec City-based biopharmaceutical company Medicago more than $300 million to develop and manufacture a …See details»